The primary endpoint of adjusted ALSFRS-R and secondary endpoints of CAFS and SVC were not met at 24 weeks Prespecified exploratory analyses of the secondary survival endpoint for the 30 mg dose demonstrated a >90% reduction in risk of death or risk of death/permanently assisted ventilation at 24 weeks Survival signal consistent with prior results […]
$67.5 million tuck-in acquisition strengthens Myriad’s Women’s Health portfolio of prenatal products.
Myriad Genetics announced financial results for its third quarter ended September 30, 2022 and provided an update on business performance.
Renalytix announced its full year results for the twelve months ended 30 June 2022.
Merit Medical Systems announced revenue of $287.2 million for the quarter ended September 30, 2022.
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2022
Renalytix announced that the Federal Medicare Administrative Contractor (MAC) National Government Services (NGS) has initiated payment of claims for KidneyIntelX testing for patients with Medicare coverage.
The Women’s Tech Council announced eight award recipients from its twenty one finalists.
Geneial announces a multimillion dollar, non-dilutive award from the National Human Genome Research Institute to fund the development of their secure, decentralized platform.
SINTX announces the receipt of a Phase II award of $1.1M, issued by the U.S. Department of Energy (DOE) to develop, design and characterize 3D-printed alumina ceramic heat exchangers for heating, ventilation, and air conditioning systems (HVAC).
SINTX announced a Phase I grant of $275k awarded by the National Institutes of Health (NIH) to develop and test an antimicrobial trauma device.
CNS Clinical Research Veteran Brings Extensive Expertise in Global Project Management & Operations